FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amneal Pharmaceuticals of New York Extended Phenytoin Sodium Capsules Recall

Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amnea…

Amneal Pharmaceuticals of New York, LLC · Brookhaven, NY

Risk level
Class II
Reported by FDA
Nov 15, 2023
Recall ID
D-0090-2024
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals of New York recalled Extended Phenytoin Sodium Capsules starting Oct 27, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0090-2024 on Nov 15, 2023. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10

Lot numbers, UPCs & expiration codes

Lot # HM03221A, Exp. date 12/31/2023

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0090-2024
Classification
Class II
Status
Terminated
Recall initiated
Oct 27, 2023
FDA report date
Nov 15, 2023
Quantity
9,263 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals of New York, LLC

Original FDA data

Every field from FDA enforcement report D-0090-2024, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Terminated
Country
United States
Event ID
93292
Address
50 Horseblock Rd
Code information
Lot # HM03221A, Exp. date 12/31/2023
Postal code
11719-9509
Report date
Nov 15, 2023
Product type
Drugs
Recall number
D-0090-2024
Classification
Class II
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Product quantity
9,263 100-count bottles
Termination date
Aug 6, 2025
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Oct 27, 2023
Initial firm notification
Letter
Center classification date
Nov 7, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0090-2024, published Nov 15, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls